# Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors

> **NCT02215928** · — · RECRUITING · sponsor: **Stanford University** · enrollment: 100 (estimated)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **GENETIC:** mutation analysis
- **OTHER:** cytology specimen collection procedure
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT02215928
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2014-07-28
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02215928

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02215928, "Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02215928. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*